Dermal Drug Selection And Development: An Industrial Perspective
by Lionel Trottet /
2017 / English / PDF
6.9 MB Download
The authors show how the pharmaceutical industry faces the
development of dermal drugs and provide the only book of its kind
that describes how the industry develops and selects dermal
drugs, complete with the challenges and opportunities of the
field. Delivery of drugs through the skin has been an attractive
and challenging area for research, and advances in modern
technologies have resulted in a larger number of drugs being
delivered transdermally, including conventional hydrophobic small
molecule drugs, hydrophilic drugs and macromolecules. Offering
the perspective from the industrial side of selection and
development of drugs, the primary audience is geared towards the
pharmaceutical industry but can also offer valuable information
to clinicians, compounding pharmacists, and similarly pharmacy
students.
The authors show how the pharmaceutical industry faces the
development of dermal drugs and provide the only book of its kind
that describes how the industry develops and selects dermal
drugs, complete with the challenges and opportunities of the
field. Delivery of drugs through the skin has been an attractive
and challenging area for research, and advances in modern
technologies have resulted in a larger number of drugs being
delivered transdermally, including conventional hydrophobic small
molecule drugs, hydrophilic drugs and macromolecules. Offering
the perspective from the industrial side of selection and
development of drugs, the primary audience is geared towards the
pharmaceutical industry but can also offer valuable information
to clinicians, compounding pharmacists, and similarly pharmacy
students.Dermal Drug Selection and Development
Dermal Drug Selection and Development covers the
covers thescientific gaps that exist in terms of dermal pharmacokinetics
and the resulting uncertainty by clinicians when choosing a drug
candidate.
scientific gaps that exist in terms of dermal pharmacokinetics
and the resulting uncertainty by clinicians when choosing a drug
candidate.
